Annual Net Income
-$34.03 M
-$2.97 M-9.57%
31 December 2023
Summary:
Lumos Pharma annual net profit is currently -$34.03 million, with the most recent change of -$2.97 million (-9.57%) on 31 December 2023. During the last 3 years, it has fallen by -$3.60 million (-11.84%).LUMO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$7.47 M
+$84.00 K+1.11%
30 September 2024
Summary:
Lumos Pharma quarterly net profit is currently -$7.47 million, with the most recent change of +$84.00 thousand (+1.11%) on 30 September 2024. Over the past year, it has increased by +$1.99 million (+21.04%).LUMO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$34.92 M
+$833.00 K+2.33%
30 September 2024
Summary:
Lumos Pharma TTM net profit is currently -$34.92 million, with the most recent change of +$833.00 thousand (+2.33%) on 30 September 2024. Over the past year, it has dropped by -$882.00 thousand (-2.59%).LUMO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +21.0% | -2.6% |
| 3 y3 years | -11.8% | -32.4% | -14.7% |
| 5 y5 years | -250.7% | -216.1% | -259.8% |
LUMO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -135.4% | -106.2% | -130.0% |
Lumos Pharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.47 M(-1.1%) | -$34.92 M(-2.3%) |
| June 2024 | - | -$7.55 M(-27.7%) | -$35.75 M(-3.7%) |
| Mar 2024 | - | -$10.44 M(+10.4%) | -$37.13 M(+9.1%) |
| Dec 2023 | -$34.03 M(+9.6%) | -$9.46 M(+13.9%) | -$34.03 M(+3.7%) |
| Sept 2023 | - | -$8.30 M(-7.1%) | -$32.82 M(+3.3%) |
| June 2023 | - | -$8.93 M(+21.6%) | -$31.77 M(-17.3%) |
| Mar 2023 | - | -$7.35 M(-10.9%) | -$38.41 M(-1.0%) |
| Dec 2022 | -$31.06 M(+2.1%) | -$8.25 M(+13.7%) | -$38.78 M(+7.2%) |
| Sept 2022 | - | -$7.25 M(-53.4%) | -$36.18 M(-0.7%) |
| June 2022 | - | -$15.56 M(+101.6%) | -$36.41 M(+23.4%) |
| Mar 2022 | - | -$7.72 M(+36.9%) | -$29.52 M(-3.0%) |
| Dec 2021 | -$30.43 M(+437.3%) | -$5.64 M(-24.7%) | -$30.43 M(+11.9%) |
| Sept 2021 | - | -$7.49 M(-13.6%) | -$27.20 M(+51.5%) |
| June 2021 | - | -$8.67 M(+0.5%) | -$17.95 M(+22.7%) |
| Mar 2021 | - | -$8.63 M(+257.4%) | -$14.63 M(+158.4%) |
| Dec 2020 | -$5.66 M(-41.6%) | -$2.42 M(-236.8%) | -$5.66 M(+0.9%) |
| Sept 2020 | - | $1.76 M(-133.0%) | -$5.61 M(-44.1%) |
| June 2020 | - | -$5.35 M(-1674.4%) | -$10.04 M(+38.3%) |
| Mar 2020 | - | $340.00 K(-114.4%) | -$7.26 M(-25.2%) |
| Dec 2019 | -$9.71 M(-81.9%) | -$2.36 M(-11.5%) | -$9.71 M(-45.8%) |
| Sept 2019 | - | -$2.67 M(+3.9%) | -$17.91 M(-20.9%) |
| June 2019 | - | -$2.57 M(+22.0%) | -$22.65 M(-39.4%) |
| Mar 2019 | - | -$2.10 M(-80.1%) | -$37.39 M(-30.2%) |
| Dec 2018 | -$53.59 M(-25.5%) | -$10.57 M(+42.8%) | -$53.59 M(-5.5%) |
| Sept 2018 | - | -$7.40 M(-57.2%) | -$56.71 M(-18.9%) |
| June 2018 | - | -$17.31 M(-5.4%) | -$69.94 M(+0.8%) |
| Mar 2018 | - | -$18.31 M(+33.8%) | -$69.35 M(-3.6%) |
| Dec 2017 | -$71.95 M | -$13.69 M(-33.6%) | -$71.95 M(+0.3%) |
| Sept 2017 | - | -$20.63 M(+23.3%) | -$71.77 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$16.73 M(-20.0%) | -$66.69 M(-19.0%) |
| Mar 2017 | - | -$20.91 M(+54.8%) | -$82.35 M(-3.3%) |
| Dec 2016 | -$85.16 M(+110.9%) | -$13.51 M(-13.1%) | -$85.16 M(-8.7%) |
| Sept 2016 | - | -$15.54 M(-52.0%) | -$93.22 M(-0.4%) |
| June 2016 | - | -$32.39 M(+36.5%) | -$93.59 M(+24.3%) |
| Mar 2016 | - | -$23.72 M(+9.9%) | -$75.29 M(+86.5%) |
| Dec 2015 | -$40.38 M(-142.1%) | -$21.57 M(+35.6%) | -$40.38 M(-139.9%) |
| Sept 2015 | - | -$15.91 M(+12.9%) | $101.21 M(-9.2%) |
| June 2015 | - | -$14.09 M(-225.9%) | $111.52 M(-4.2%) |
| Mar 2015 | - | $11.19 M(-90.7%) | $116.44 M(+21.3%) |
| Dec 2014 | $96.02 M(-407.9%) | $120.01 M(-2243.9%) | $96.02 M(-399.6%) |
| Sept 2014 | - | -$5.60 M(-38.9%) | -$32.04 M(-7.3%) |
| June 2014 | - | -$9.16 M(-0.8%) | -$34.57 M(+6.4%) |
| Mar 2014 | - | -$9.24 M(+14.8%) | -$32.48 M(+4.2%) |
| Dec 2013 | -$31.18 M(+33.7%) | -$8.05 M(-0.9%) | -$31.18 M(+5.9%) |
| Sept 2013 | - | -$8.12 M(+14.8%) | -$29.45 M(+8.4%) |
| June 2013 | - | -$7.08 M(-10.8%) | -$27.18 M(+2.9%) |
| Mar 2013 | - | -$7.93 M(+25.6%) | -$26.41 M(+13.3%) |
| Dec 2012 | -$23.32 M(+28.9%) | -$6.32 M(+8.0%) | -$23.32 M(+2.2%) |
| Sept 2012 | - | -$5.85 M(-7.3%) | -$22.81 M(+8.9%) |
| June 2012 | - | -$6.31 M(+30.3%) | -$20.95 M(+10.1%) |
| Mar 2012 | - | -$4.84 M(-16.7%) | -$19.03 M(+5.2%) |
| Dec 2011 | -$18.09 M(+11.6%) | -$5.81 M(+45.8%) | -$18.09 M(+10.5%) |
| Sept 2011 | - | -$3.99 M(-9.3%) | -$16.37 M(-6.0%) |
| June 2011 | - | -$4.39 M(+12.8%) | -$17.42 M(+33.7%) |
| Mar 2011 | - | -$3.90 M(-4.8%) | -$13.02 M(+42.7%) |
| Dec 2010 | -$16.21 M(+62.6%) | -$4.09 M(-18.6%) | -$9.13 M(+19.5%) |
| Sept 2010 | - | -$5.03 M(+93.0%) | -$7.64 M(+193.0%) |
| Dec 2009 | -$9.97 M(+8.9%) | -$2.61 M | -$2.61 M |
| Dec 2008 | -$9.16 M | - | - |
FAQ
- What is Lumos Pharma annual net profit?
- What is the all time high annual net income for Lumos Pharma?
- What is Lumos Pharma quarterly net profit?
- What is the all time high quarterly net income for Lumos Pharma?
- What is Lumos Pharma quarterly net income year-on-year change?
- What is Lumos Pharma TTM net profit?
- What is the all time high TTM net income for Lumos Pharma?
- What is Lumos Pharma TTM net income year-on-year change?
What is Lumos Pharma annual net profit?
The current annual net income of LUMO is -$34.03 M
What is the all time high annual net income for Lumos Pharma?
Lumos Pharma all-time high annual net profit is $96.02 M
What is Lumos Pharma quarterly net profit?
The current quarterly net income of LUMO is -$7.47 M
What is the all time high quarterly net income for Lumos Pharma?
Lumos Pharma all-time high quarterly net profit is $120.01 M
What is Lumos Pharma quarterly net income year-on-year change?
Over the past year, LUMO quarterly net profit has changed by +$1.99 M (+21.04%)
What is Lumos Pharma TTM net profit?
The current TTM net income of LUMO is -$34.92 M
What is the all time high TTM net income for Lumos Pharma?
Lumos Pharma all-time high TTM net profit is $116.44 M
What is Lumos Pharma TTM net income year-on-year change?
Over the past year, LUMO TTM net profit has changed by -$882.00 K (-2.59%)